A shocking new report defies the chronically underestimated impacts of the Fukushima’s triple meltdown on the risk of cancer in exposed populations, which does not just include Japan, but arguably the entire world.
A new report from Fairewinds Energy Education (FEE), “Cancer on the Rise in Post-Fukushima Japan,” reveals that the ongoing multi-core nuclear meltdown at the Fukushima Daiichi plant that started in March 2011 has produced approximately 230 times higher than normal thyroid cancers in Fukushima Prefecture, and could result in as many as one million more cancers in Japan’s future as a result of the meltdown.
According to the new report, data provided by a group of esteemed Japanese medical professionals and TEPCO, confirm a direct link of numerous cancers in Japan to the triple meltdown.
As transcribed by Enenews.com, Arnie Gundersen, chief engineer at Fairewinds stated, Nov. 4, 2015:
“It’s been almost 5 years from the Fukushima Daiichi meltdowns, and the news from Japan is still not good. Two reports recently released in Japan, one by Japanese medical professionals and the second from Tokyo Power Corporation – TEPCO – acknowledged that there will be numerous cancers in Japan, much greater than normal, due to the radioactive discharges from the triple meltdown at Fukushima Daiichi…
I believe, as do many of my colleagues, that there will be at least 100,000 and as many as one million more cancers in Japan’s future as a result of this meltdown… [T]he second report received from Japan proves that the incidence of thyroid cancer is approximately 230 times higher than normal in Fukushima Prefecture… So what’s the bottom line? The cancers already occurring in Japan are just the tip of the iceberg. I’m sorry to say that the worst is yet to come.”